Inside Ozzy Osbourne’s ‘very rare’ Parkinson’s diagnosis years after symptoms started
Ozzy Osbourne has been battling a rare form of Parkinson's Disease known as Parkin 2. In 2020, he disclosed to his fans that ...
Rolling Out9d
A breakthrough in Parkinson’s disease detection
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
Healthline23d
Is There a Link Between ADHD and Parkinson’s Disease?
Attention deficit hyperactivity disorder (ADHD) and Parkinson’s disease are distinct neurological conditions. They typically onset at different life stages: ADHD in childhood and Parkinson’s ...
Ozzy Osbourne to Hit the Stage With Black Sabbath Amid Debilitating Parkinson's Battle
All aboard the "Crazy Train" — Black Sabbath will be reuniting for a performance in Ozzy Osbourne's hometown of Birmingham, U ...
Knowridge3d
New research links kidney failure to Parkinson’s disease
Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...
Healio3d
GLP-1 does not slow Parkinson’s disease progression in phase 3 study
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
BioSpace9d
Inhibikase Scraps Parkinson’s Drug After Disappointing Mid-Stage Data
Inhibikase’s setback continues biopharma’s losing streak against Parkinson’s, marked by several clinical failures and ...
manilatimes1mon
Roche's Phase IIb study of prasinezumab missed primary endpoint, but suggests possible benefit in early-stage Parkinson's disease
About the PADOVA study PADOVA is a Phase IIb multicentre, randomised, double-blind trial evaluating the efficacy and safety of prasinezumab compared with placebo in 586 randomised patients with ...